Pelvic exenteration: a review of the Gateshead experience 1974-1992
- PMID: 8018644
- DOI: 10.1111/j.1471-0528.1994.tb13156.x
Pelvic exenteration: a review of the Gateshead experience 1974-1992
Abstract
Objective: To examine morbidity and survival among women treated by pelvic exenteration for gynaecological malignancy.
Design: Retrospective review by analysis of case records.
Setting: Department of Gynaecological Oncology, Queen Elizabeth Hospital, Gateshead, UK.
Subjects: Eighty-three consecutive patients referred from within the UK from 1974 to 1992 for initial treatment of advanced gynaecological malignancy or management of recurrent disease following unsuccessful initial therapy.
Results: Overall five year actuarial survival was 41%, falling to 36% at 10 years. Serious morbidity was low, and there were only three peri-operative deaths.
Conclusions: For patients with limited options for treatment of advanced primary or recurrent cancer, exenteration offers a reasonable prospect of survival with good quality of life.